Journal Article DKFZ-2026-00325

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Co-administered internalizing RGD peptide boosts anti-PD-L1 therapy in hepatocellular carcinoma

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2026
Elsevier Amsterdam

JHEP reports 8(3), 101731 () [10.1016/j.jhepr.2026.101731]
 GO

Classification:

Contributing Institute(s):
  1. DKTK Koordinierungsstelle Frankfurt (FM01)
Research Program(s):
  1. 899 - ohne Topic (POF4-899) (POF4-899)

Appears in the scientific report 2026
Database coverage:
Medline ; DOAJ ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2026-02-12, last modified 2026-02-12



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)